Your browser doesn't support javascript.
Modeling the impact of delaying transcatheter aortic valve replacement for the treatment of aortic stenosis in the era of COVID-19.
Freno, Daniel R; Shipe, Maren E; Levack, Melissa M; Shah, Ashish S; Deppen, Stephen A; O'Leary, Jared M; Grogan, Eric L.
  • Freno DR; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
  • Shipe ME; Department of General Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
  • Levack MM; Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
  • Shah AS; Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
  • Deppen SA; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
  • O'Leary JM; Tennessee Valley Healthcare System, Department of Surgery, Nashville, Tenn.
  • Grogan EL; Department of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
JTCVS Open ; 7: 63-71, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1740300
ABSTRACT

OBJECTIVE:

The aim of this study was to model the short term and 2-year overall survival (OS) for intermediate-risk and low-risk patients with severe symptomatic aortic stenosis (AS) undergoing timely or delayed transcatheter aortic valve replacement (TAVR) during the 2019 novel coronavirus (COVID-19) pandemic.

METHODS:

We developed a decision analysis model to evaluate 2 treatment strategies for both low-risk and intermediate-risk patients with AS during the COVID-19 novel coronavirus pandemic.

RESULTS:

Prompt TAVR resulted in improved 2-year OS compared with delayed intervention for intermediate-risk patients (0.81 vs 0.67) and low-risk patients (0.95 vs 0.85), owing to the risk of death or the need for urgent/emergent TAVR in the waiting period. However, if the probability of acquiring COVID-19 novel coronavirus is >55% (intermediate-risk patients) or 47% (low-risk patients), delayed TAVR is favored over prompt intervention (0.66 vs 0.67 for intermediate risk; 0.84 vs 0.85 for low risk).

CONCLUSIONS:

Prompt transcatheter aortic valve replacement for both intermediate-risk and low-risk patients with symptomatic severe AS results in improved 2-year survival when local healthcare system resources are not significantly constrained by the COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: JTCVS Open Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: JTCVS Open Year: 2021 Document Type: Article